Ocular Therapeutix Inc (OCUL)
6.17
+0.30
(+5.11%)
USD |
NASDAQ |
May 03, 16:00
6.16
-0.01
(-0.16%)
After-Hours: 20:00
Ocular Therapeutix Total Return Level: 6.17 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 6.17 |
May 02, 2024 | 5.87 |
May 01, 2024 | 5.02 |
April 30, 2024 | 4.74 |
April 29, 2024 | 4.80 |
April 26, 2024 | 4.745 |
April 25, 2024 | 4.20 |
April 24, 2024 | 4.645 |
April 23, 2024 | 5.00 |
April 22, 2024 | 5.075 |
April 19, 2024 | 5.22 |
April 18, 2024 | 5.86 |
April 17, 2024 | 7.58 |
April 16, 2024 | 7.79 |
April 15, 2024 | 7.80 |
April 12, 2024 | 7.99 |
April 11, 2024 | 8.28 |
April 10, 2024 | 7.91 |
April 09, 2024 | 8.17 |
April 08, 2024 | 7.99 |
April 05, 2024 | 8.44 |
April 04, 2024 | 8.47 |
April 03, 2024 | 8.45 |
April 02, 2024 | 8.48 |
April 01, 2024 | 8.69 |
Date | Value |
---|---|
March 28, 2024 | 9.10 |
March 27, 2024 | 9.31 |
March 26, 2024 | 9.20 |
March 25, 2024 | 9.41 |
March 22, 2024 | 9.49 |
March 21, 2024 | 10.15 |
March 20, 2024 | 9.90 |
March 19, 2024 | 9.70 |
March 18, 2024 | 9.44 |
March 15, 2024 | 9.46 |
March 14, 2024 | 9.26 |
March 13, 2024 | 9.59 |
March 12, 2024 | 9.29 |
March 11, 2024 | 9.73 |
March 08, 2024 | 9.98 |
March 07, 2024 | 10.37 |
March 06, 2024 | 10.83 |
March 05, 2024 | 10.93 |
March 04, 2024 | 10.88 |
March 01, 2024 | 10.75 |
February 29, 2024 | 10.06 |
February 28, 2024 | 9.95 |
February 27, 2024 | 9.90 |
February 26, 2024 | 9.90 |
February 23, 2024 | 9.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.08
Minimum
Nov 16 2023
22.95
Maximum
Dec 15 2020
7.162
Average
5.26
Median
Aug 23 2022
Total Return Level Benchmarks
Amgen Inc | 432.76 |
Assertio Holdings Inc | 1.03 |
CytomX Therapeutics Inc | 4.43 |
EyePoint Pharmaceuticals Inc | 19.74 |
Regeneron Pharmaceuticals Inc | 957.00 |